Regeneron Pharmaceuticals said it will acquire 23andMe's business. What happened to 23andMe? Should you delete your data?

Regeneron Pharmaceuticals said on Monday it will buy genomics firm 23andMe Holding for $256 million through a bankruptcy ...

Drugmaker Regeneron Pharmaceuticals will buy genetic testing firm 23andMe for $256 million through a bankruptcy auction, the ...

Drugmaker Regeneron Pharmaceuticals says it will comply with privacy policies regarding the use of customer data. 23andMe's ...

The sale was for $256 million and is expected to be complete by the third quarter of this year, according to a Regeneron news ...

The DNA testing company would sell for a fraction of its peak valuation of $6 billion to a biotech aiming to use its data ...

Biotechnology company Regeneron will acquire 23andMe out of bankruptcy for $256 million, with a plan to keep the DNA-testing ...

Regeneron Pharmaceuticals will acquire embattled DNA testing company 23andMe in a $256 million court-supervised sale, ...

Drugmaker Regeneron Pharmaceuticals will buy genetic testing firm 23andMe for $256 million through ... from 15 million customers who ordered its DNA testing kits online and provided saliva samples.

The top bidder in the DNA testing firm's bankruptcy auction, Regeneron vows to prioritize the privacy, security, and ethical ...

STORY: Regeneron Pharmaceuticals said on Monday it will buy genetic testing firm 23andMe Holding for $256 million through a ...

The biotech, which has for years invested in genetics research, plans to acquire "substantially all" of testing firm ...